| Fri 26 Aug 2011, 8:30 | | MDC - Medi-Clinic Corporation Limited - Finalisation announcement relating |
|
MDC
MDC
MDC - Medi-Clinic Corporation Limited - Finalisation announcement relating
to the change of company name
Medi-Clinic Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE0000074142
Share Code: MDC
("the Company")
FINALISATION ANNOUNCEMENT RELATING TO THE CHANGE OF COMPANY NAME
Further to the announcement released on SENS on 27 July 2011 and published
in the South African press on 28 July 2011 relating to the change of the
Company`s name from "Medi-Clinic Corporation Limited" to "Mediclinic
International Limited", shareholders are advised that the change of the
Company`s name was registered with the Companies and Intellectual Property
Commission. The Company`s abbreviated name "Medclin", the JSE share code
"MDC", as well as the ISIN number ZAE000074142 will remain unchanged. There
being no further conditions precedent outstanding, the salient dates and
times in respect of the name change are as follows:
Last date to trade under the old name Friday, 2 September 2011
(Medi-Clinic Corporation Limited)
Commencement of trading under the new Monday,5 September 2011
name (Mediclinic International Limited)
Record date Friday, 9 September 2011
Stellenbosch
26 August 2011
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 26/08/2011 08:30:00 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
